KEY2BRAIN
Live / Applied — Non-final action written — not yet mailed (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 14 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79437432
- Mark type
- Stylized text
- Filed
- 14 Oct 2025
Goods and services
- Class 001 — Chemicals: Chemical substances for use in the production of drugs; biological preparations for use in industry and science; biological preparations for use in science.
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of central nervous system [cns] diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders.
- Class 042 — Scientific and technological services: Technological research; technological services and research relating thereto; design and development of medical technology; science and technology services; technological analysis services; consultancy relating to biotechnology; research and development in the field of biotechnology; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to molecular sciences; analysis in the field of molecular biology; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical drug development services; research and development for the pharmaceutical industry; consultancy relating to pharmaceutical research and development; technical research in the field of pharmaceutical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Owner
- Key2Brain AB, SE
Prosecution history
- 12 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 11 Mar 2026 — NON-FINAL ACTION WRITTEN
- 03 Mar 2026 — ASSIGNED TO EXAMINER
- 21 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB